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Background: Healthcare decision makers face challenges when using guidelines, including understanding the
quality of the evidence or the values and preferences upon which recommendations are made, which are often
not clear.
Methods: GRADE is a systematic approach towards assessing the quality of evidence and the strength of
recommendations in healthcare. GRADE also gives advice on how to go from evidence to decisions. It has been
developed to address the weaknesses of other grading systems and is now widely used internationally. The
Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on
Evidence (DECIDE) consortium (http://www.decide-collaboration.eu/), which includes members of the GRADE
Working Group and other partners, will explore methods to ensure effective communication of evidence-based
recommendations targeted at key stakeholders: healthcare professionals, policymakers, and managers, as well as
patients and the general public. Surveys and interviews with guideline producers and other stakeholders will
explore how presentation of the evidence could be improved to better meet their information needs. We will
collect further stakeholder input from advisory groups, via consultations and user testing; this will be done across a
wide range of healthcare systems in Europe, North America, and other countries. Targeted communication
strategies will be developed, evaluated in randomized trials, refined, and assessed during the development of real
guidelines.
Discussion: Results of the DECIDE project will improve the communication of evidence-based healthcare
recommendations. Building on the work of the GRADE Working Group, DECIDE will develop and evaluate methods
that address communication needs of guideline users. The project will produce strategies for communicating
recommendations that have been rigorously evaluated in diverse settings, and it will support the transfer of
research into practice in healthcare systems globally.
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Health professionals, patients, policymakers, and the public
aspire to making healthcare decisions on the basis of the
best available research evidence [1-6]. However, experience
shows that this frequently is not achieved [7-10]. Reasons
for this deficiency include the overwhelming amount of re-
search literature, the sometimes contradictory nature of
this literature, and presentations that are difficult for non-
researchers to understand [11,12]. The complexity of the
problems encountered both in patient encounters (e.g.,
multimorbidy) and health policy decision-making mean
that applying research evidence is not straightforward.
Clinical practice guidelines and health technology assess-
ments have emerged as a source of support. Clinical prac-
tice guidelines are becoming increasingly popular, i.e.,
statements that include recommendations intended to
optimize patient care that should be informed by a system-
atic review of evidence and an assessment of the benefits
and harms of alternative care options [13,14].
Guidelines are considered a convenient way of pack-
aging evidence and present recommendations to health-
care decision makers. Nevertheless, decisions should be
influenced not only by the best estimates of the
expected benefits and harms of a therapy or interven-
tion but also by other factors. These include the confi-
dence in these estimates (quality of the evidence),
patient values, preferences, and for policy makers in
particular, resource use, feasibility, and equity might
also be relevant. Guideline developers have been incon-
sistent in how they rate quality of evidence and grade
strength of recommendations, despite the critical role
of these processes in guideline production [15]. As a re-
sult, guideline users face challenges in understanding
guidelines’ messages and question their rigour, limiting
their trustworthiness. Bridging the gap between clinical
research and everyday healthcare practice requires more
effective communication strategies.Table 1 DECIDE Partners
Partner number Participant organisation name
1 University of Dundee
2 Norwegian Knowledge Centre for the Health Ser
3 Biomedical Research Institute (IIB-Sant Pau)
4 Lazio Regional Health Service, Department of Epi
5 University of Amsterdam
6 World Health Organisation
7 University Hospital, Freiburg
8 National Institute for Health and Clinical Excellen
9 Scottish Intercollegiate Guidelines Network
10 Finnish Medical Society DuodecimThe GRADE system
The GRADE Working Group—a widely representative
international group of guideline developers, health pro-
fessionals, epidemiologists and statisticians—has spent
over a decade developing an approach towards assessing
and communicating the quality of evidence and the
strength of recommendations (www.gradeworkinggroup.
org). The GRADE approach is now well-established and
is widely used internationally [16-20].
The GRADE Working Group has focused on a system
for structuring judgements about the quality of evidence
and characterising the strength of recommendations. In
addition, the Working Group has developed and evaluated
ways of presenting concise summaries of the findings of
systematic reviews (as the basis for recommendations or
decisions) to health professionals, and has contributed to
ways of presenting this information to guideline developers,
policymakers and patients [21-28]. The group has also
addressed considerations for applying the GRADE system
to recommendations about diagnostic tests and health sys-
tem policies [23,24,29]. This work has been essential but
does not address issues around how best to present and de-
liver GRADE recommendations to health professionals,
policymakers, patients, and others. The Developing and
Evaluating Communication Strategies to Support Informed
Decisions and Practice Based on Evidence (DECIDE) pro-
ject aims to build on this work by developing and evaluat-
ing ways of effectively communicating evidence-based
recommendations to different target groups (see Table 1
for the list of DECIDE partners).
Aims and objectives
DECIDE’s objectives are to develop and evaluate strat-
egies for the targeted communication of evidence-
based recommendations to the key stakeholders who
determine what happens in healthcare. We will develop
and evaluate strategies for effectively and efficientlyParticipant short name Country
UNIVDUN United Kingdom
vices KS Norway
SANTPAU Spain
demiology ASL RME.DE Italy
UA Netherlands
WHO International
UHF Germany
ce NICE United Kingdom
SIGN United Kingdom
FMS Finland
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based recommendations to: healthcare professionals;
policymakers and managers; and patients and the gen-
eral public.
In addition to addressing recommendations about pre-
vention, treatment, and rehabilitation, we will develop strat-
egies for recommendations about diagnostic tests (targeted
mainly at healthcare professionals but could be others) and
health system policies (targeted mainly at policymakers).
To ensure wide communication of DECIDE’s results we
will: develop a tool kit for preparing and effectively com-
municating evidence-based recommendations; develop a
database of evidence profiles (see ‘Development of a data-
base of evidence profiles’ below); and host a European
conference on promoting the optimal development and
communication of evidence based recommendations.
DECIDE as originally envisaged has not been placed in a
particular knowledge transfer or implementation frame-
work. Instead, it aims to provide empirical support for a
range of communication strategies, particularly how re-
search evidence is presented to users to optimize access
and use of the information contained within guidelines. A
recent framework for guideline implementability [30]
does, however, support many of the approaches taken by
DECIDE, for example, tailoring guidelines for different
types of user, grading evidence, presenting research evi-
dence in a range of formats, considering how recommen-
dations are presented, improved navigation, presenting
information on patients’ and others’ preferences and
values, information on costs, and providing information to
support shared decisions between patients and clinicians.
So, while DECIDE, is not explicitly placed within any par-
ticular knowledge transfer framework, it addresses key fea-
tures of guidelines that are consistent with recent efforts
to develop a guideline implementation framework.
DECIDE started on 1 January 2011 and will run for
five years (http://www.decide-collaboration.eu/).
Methods
The DECIDE project has organized its empirical work
around five work packages (WPs), each aimed at a differ-
ent stakeholder group or type of recommendation:
health professionals (WP1); policymakers and managers
(WP2); public, patients and carers (WP3); diagnostic
tests (WP4); and health system policies (WP5).
There are three other work packages in DECIDE: WP6
will develop a toolkit for preparing and disseminating
evidence-based recommendations (see below); WP7 will
support communication; and WP8 is project management.
All work packages involve work in all DECIDE partner
countries, namely Finland, Germany, Italy, the Netherlands,
Norway, Spain, and the United Kingdom (UK) (see
Table 1). Through collaboration with our World Health Or-
ganisation (WHO) partner, the GRADE Working Group,and the Guidelines International Network (G-I-N), this
work will extend to other European countries, North
America, and elsewhere.
Although work packages may develop different commu-
nication strategies, each focused on the needs of the par-
ticular stakeholder group, each of work packages 1 – 5
will use a similar approach to developing its strategies.
This will comprise three phases:Phase one: strategy development and user testing
This work will collect user feedback from people in each of
the targeted groups (e.g., health professionals) through user
testing, plus feedback from key stakeholders, for example,
people who author guidelines. We will analyse feedback,
define problem areas, and revise the strategies in brain-
storming workshops. Additionally, we will survey user per-
ceptions of a variety of current guidelines and their
preferences regarding guideline content and presentation.Phase two: evaluating the communication strategies
The strategies coming from phase one will be evaluated,
generally in randomized trials. The evaluations will be
tailored to the different groups being targeted (i.e.,
health professionals, policymakers and patients) and the
different types of interventions (treatment, diagnostic
and health systems).Phase three: testing our strategies with real guidelines
The strategies developed in phase two will be tested by
using them prospectively in real guidelines prepared by
consortium partners and collaborators. We will evaluate
the impacts of these strategies on outcomes such as
knowledge, attitudes and self-reported behaviour using
surveys and interviews.
DECIDE will also develop a toolkit for guideline devel-
opers to support them in developing and communicat-
ing evidence-based recommendations using the DECIDE
strategies, which will include a database of evidence pro-
files (see ‘Strategies for collaboration among European
guideline developers and health technology assessment
agencies in Europe (WP6)’ below).
A simplified flow diagram of how the three phases of
DECIDE will work in practice is given in Figure 1. The
diagram is illustrative; we do not know at this stage how
many strategies will go into phase two before the com-
pletion of phase one. The components of phase one will
be staggered, rather than parallel. Moreover, the process
will be iterative within phases (see Figure 2) and between
phases in that we anticipate returning to, for example,
phase one in light of what we learn in phase two.
Finally, ethics approval will be sought for each of DECI-
DE’s studies separately according to national regulations.
Development and user-testing 
of presentations A, B and C
Trial of A Trial of C
Test A in a real 
guideline
Test C in a real 
guideline
Trial of B
Figure 1 Simplified flow diagram of how the three phases of
DECIDE will work.
Figure 2 The iterative nature of the DECIDE strategy
development process.
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Our initial development of communication strategies to
effectively communicate evidence-based recommenda-
tions to stakeholders will be based on the work of the
GRADE Working Group, Cochrane Collaboration Sum-
mary of Findings [21,22,31,32], SUPPORT summaries for
policymakers and managers (www.support-collaboration.
org/) [23,24], and plain language summaries for patients
and the general public [25-27]. From this starting point,
we will use multiple methods to develop templates for
presenting evidence-based recommendations, supporting
material, and communication strategies to health profes-
sionals, policymakers, or the public:
1. Brainstorming workshops (e.g., with DECIDE
partners) to generate ideas and solutions to problems
uncovered through feedback and testing.
2. Literature reviews to inform development of
communication strategies.
3. Stakeholder feedback (e.g., from health professionals,
policymakers, guideline authors) to inform
development and revisions from diverse perspectives.
4. User testing (e.g., with members of the public). To
inform revisions from a user perspective.
5. Surveys of users to explore their understanding of
guidelines and perceptions of a variety of current
guidelines and their preferences regarding guideline
content and presentation.
Brainstorming workshops
At a minimum, brainstorming workshops with DECIDE
partners working on each work package will take place at
each annual project meeting and then after each round of
stakeholder group feedback and user testing. We will
apply principles from our professional perspectives includ-
ing clinical epidemiology and information design, as well
as diverse clinical backgrounds and experience developing
and using guidelines. We will identify problems with these
examples and ways in which communication could be
improved by changes in presentation of the tables and
recommendations, accompanying materials, and support-
ive strategies.
Literature reviews
If relevant reviews do not already exist, then work
packages will do one or more reviews to collate what is
known about guideline dissemination methods for par-
ticular target groups. WP3, for example, will review the
literature covering the evidence around patient (lay, pub-
lic, citizen, consumer) beliefs, feelings, awareness, under-
standing and knowledge, expectation and perception of
healthcare guidelines, and to collate knowledge on meth-
ods of communicating guideline recommendations to
this audience. WP4 will review the grading systems used
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work on how this might be improved and how the results
of the grading might best be presented. WP1 will do two
rapid systematic reviews, one looking at how guidelines and
secondary resources (e.g., UptoDate) present recommenda-
tions and evidence summaries, and a second looking for
what has been studied about the different aspects around
presentation of recommendations and evidence summaries.
The results of all these reviews will inform DECIDE’s work,
as well as advance knowledge around presenting guideline
information to a wide range of stakeholders.
Stakeholder feedback
DECIDE’s communication strategies will be informed by
wide consultation with stakeholder groups. Each of work
packages 1 – 6 will have an advisory group, comprising
stakeholders relevant to the work package such as health
professionals from diverse settings, guideline developers,
policymakers, members of the public, patients and patient
representatives, journalists, and researchers with expertise
in clinical epidemiology and statistics, implementation sci-
ence, communication, and psychology. Groups will be
purposely selected to ensure a breadth of perspectives and
will provide guidance on strategy, protocols, and specific
approaches and tools throughout the project.
We will prepare summaries and recommendations for
selected clinical topics using the strategies that are agreed
on at the first brainstorming workshop. We will include
topics that could be relevant to all partners (e.g., depres-
sion, or cervical cancer screening). Less frequently, topics
might be of interest to a single or just some participant
countries. The summaries and recommendations we pre-
pare will be used as the basis for gathering feedback on
the format, content and delivery method of GRADE
evidence-based recommendations and supporting materi-
als in all of the participating countries. It is hard to predict
what issues stakeholders will raise, but feedback could, for
example, relate to the merits of quantitative versus qualita-
tive presentation of information, the quality of information
presented, or information missing from presentations.
We will consult stakeholders by email, encouraging
them to collect feedback from their colleagues or con-
stituencies when reporting back to us. In some cases, it
may be more appropriate to use face-to-face discussions
or focus groups. Our analysis will consider issues with a
high level of agreement or disagreement, issues we had
not previously considered, or issues considered to be of
critical importance. We will consult the stakeholder
groups as needed throughout the project.
User testing
Participants from each partner country will take part in
the user tests. The type of participant will vary depend-
ing on the work package (e.g., health professionals forWP1, policymakers for WP2) and the stage of the work
(e.g., WP3 may start work with members of the public,
but also discuss communication strategies with health
professionals as the work progresses). We will guide test
participants through a series of questions to explore
which parts of the recommendations and supporting
materials cause them problems, probing to better under-
stand the nature of these problems.
We will use methods that members of the consortium
have used for similar work [21-27]. In brief, each user
test will take approximately one hour. Generally, and
with the participant or participants’ written permission,
we will audio-record each test, and an observer will take
notes. Using a semi-structured interview guide, we will
explore both immediate first impressions as well as
detailed descriptions. The interview guide will be
designed to explore seven different facets of ‘user experi-
ence’ (as originally described in a model by Peter Morville,
[33] and adjusted after evaluation in a set of studies
[34]): findability, usefulness, usability, understandability,
credibility, desirability, and affiliation). The eighth facet
from this model, accessibility, will not be addressed if user
testing is done on paper, but will be explored if user
testing is done with electronic presentations. Follow-up
questions will cover overall impressions and suggestions
for improvement.
We will review all of the notes and transcriptions,
looking primarily for barriers and facilitators related to
correct interpretation, ease of use, and favourable recep-
tion. We will trace findings back to specific elements or
characteristics of the materials that appeared to facilitate
or hinder problems. We will rate findings in three cat-
egories according to the severity of the problem for the
user: high (causes incorrect interpretation, critical errors
or high degree of uncertainty or dissatisfaction); medium
(causes much frustration or unnecessarily slow use); or
low (minor or cosmetic problems). We will also register
nice-to-haves (things users explicitly liked) and sugges-
tions for improvement.Surveys
We will survey representative samples of our targeted
users (e.g., the public or policymakers) regarding their
understanding of guidelines, or their perceptions of a
variety of current guidelines on the same topic (e.g., the
G-I-N, with which our consortium collaborates, lists 23
guidelines on atrial fibrillation, 103 on stroke, 26 on falls
in the elderly, and 41 on prevention and intervention in
influenza) and their preferences regarding guideline con-
tent, presentation of recommendations and current
strategies used to disseminate research evidence. The
surveys may also be used to evaluate alternative poten-
tial presentations formats. For example, we might ask
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electronic guideline presentations.
The results of phase one will be collated and lead to a
number of potential DECIDE strategies that will go on
to phase two (evaluation).
Phase two: evaluating the communication strategies
The various DECIDE strategies coming from phase one
will be rigorously evaluated in partner countries, gener-
ally through a randomized trial. These strategies are
likely to include the way documents are worded, how
numerical information is summarized, graphical presen-
tations, layering of information and electronic versus
paper presentations. The strategies may differ between
work packages although common elements are likely
(e.g., common explanations of terminology). The objec-
tives of the evaluations are to assess the impact of the
various DECIDE strategies on intended behaviour and
attitudes, as well as correct comprehension of key infor-
mation and general satisfaction.
We will use a range of methods to run the evaluations,
depending on the stakeholder group being targeted. For
health professionals, we aim to conduct trials at health
professional continuing education meetings such as
rounds, workshops, and conferences in each of the
DECIDE partner countries. Where possible, we will also
target guideline users when they consult guidelines on-
line in their clinical practice, when they visit websites of
guideline developers, or through their scientific societies.
Only practicing health professionals will be included.
Members of the GRADE Working Group and people
who have participated in developing the DECIDE strat-
egies will be excluded. For policymakers, we will organize
meetings with policymakers in each of the DECIDE part-
ner countries. We will include policymakers and man-
agers responsible for making or advising decisions about
coverage, funding, and implementation of clinical prac-
tice guidelines or quality of care. Trials involving the
public will involve mailing materials to individuals by
post, or email, using a variety of methods, including
those from earlier work presenting participants with sce-
narios and then measuring attitudes and intended behav-
iour [35]. Participants will be identified in a variety of
ways, including through health databases, registers of
individuals interested in taking part in research, and pub-
lic and patient groups.
In each trial, we will randomize participants to receive
information and clinical recommendations using one of
the proposed DECIDE strategies for that work package or
an alternative, which might be a conventional strategy
(e.g., a recommendation taken verbatim from one or more
existing guidelines), or another DECIDE strategy. Discus-
sions with stakeholder groups will provide us with esti-
mates of the minimal important difference in outcomesupon which to base sample size calculations. The trial
questionnaires will include multiple-choice questions
measuring correct comprehension of the specific recom-
mendation and supporting material, attitudes, hypothetical
or intended behaviour, and satisfaction. The measurement
of attitude and intention will be informed by appropriate
behavioural theory. Participants’ responses will be an-
onymous. Where the trial is run as a face-to-face meeting,
structured discussions will be carried out at the end of the
meeting, and we will interview selected participants to ex-
plore strengths and weaknesses of the strategies, reasons
for their success or failure, and ways of improving them.
These trials will tell us if one or more of the DECIDE
strategies supports increased understanding, user satis-
faction, and/or behaviours (e.g., intention to prescribe a
particular drug supported by a recommendation). For
example, we may find that one DECIDE communication
strategy allows participants to both find and understand
the balance of benefits and harms much better than a
second DECIDE strategy and the existing guideline pres-
entation. Another trial might have clinicians reviewing a
number of clinical scenarios after first having been pre-
sented with guideline recommendations presented in one
of two formats. For example, measurement of intention to
refer patients in the scenarios to screening may be more
closely aligned with the guideline recommendations with
one format than another. If participants are not too het-
erogeneous it may be possible to pool results from several
trials. Interview data will help to explain and interpret the
results of the quantitative analysis. The trials will allow us
to sift out the least promising strategies prior to moving to
phase three.Phase three: testing our strategies with real guidelines
The most promising DECIDE strategies for each work
package will be revised as needed based on the results of
phase two. The revised strategies will then be tested by
using them with real clinical practice guidelines prepared
by DECIDE partners and other collaborators. Other devel-
opers linked to the GRADE Working Group will also be
involved (see http://www.gradeworkinggroup.org/society/
index.htm). These guideline developers will use the strat-
egies for communicating evidence-based recommenda-
tions and the supporting material generated during phases
one and two with their new or updated guidelines. We will
test our strategies for optimal dissemination of recom-
mendations through different designs such as interrupted
time series, surveys and randomized trials of alternative
presentation formats.
We will evaluate the impacts of these strategies on
knowledge, attitudes, and self-reported behaviour of
guideline users using electronic means (email or web-
based systems) before and after the DECIDE strategies are
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views (after communication of the recommendations).Strategies for collaboration among European guideline
developers and health technology assessment agencies in
Europe (WP6)
We will develop a toolkit for preparing and communi-
cating evidence-based recommendations. Development
of the toolkit will be based on the GRADE profiler
(GRADEpro) software developed by members of the
GRADE Working Group and used by a wide variety of
organisations, including the DECIDE partners. GRA-
DEpro is an application for developing, managing, and
sharing evidence profiles and Summary Of Findings
Tables and making recommendations. This tool is
intended for authors of systematic reviews, guideline
developers, and those requiring summaries of the best
available evidence for recommendations about particu-
lar courses of action in healthcare. An evidence table is
a key tool in the presentation of evidence and the cor-
responding results, and it displays the information
about all outcomes for a given healthcare question in
tabular format, information that should include a sys-
tematic review of the best available evidence. Health
professionals, patients and the public, guideline develo-
pers, and policymakers should be able to access suc-
cinct, explicit, and structured evidence summaries to
inform their decisions. While an unambiguous health-
care question is key to evidence summaries, the require-
ments for specific users may differ in content and detail.
The Decision Table, another table developed by GRADE-
pro, includes the rationale for making recommendations
based on the underlying quality of evidence, the balance
between benefits and harms, values and preferences, and
resource considerations. This table is used to lay out judg-
ments that guideline developers make when they develop
recommendations [36].
As part of the DECIDE project, we will further develop
GRADEpro to incorporate presentations (including recom-
mendations, text, tables and, if appropriate, figures) devel-
oped in the five empirical work packages described above
(i.e., WPs 1 to 5) to support communication to health pro-
fessionals, policymakers, and members of the public, as
appropriate. The software will support materials in several
languages including Dutch, English, French, German,
Italian and Spanish. We will encourage GRADE members
from other European countries to provide a translation for
their country’s language. The revised and expanded soft-
ware will be tested by all of the DECIDE partners and by
other members of the GRADE Working Group and users,
including Cochrane Collaboration review authors. The
final product will be an interactive, browser-based guide-
line development tool.Development of a database of evidence profiles
To facilitate collaboration across European guideline
developers, we will develop a database of evidence pro-
files prepared using GRADEpro and the strategies devel-
oped by DECIDE. An evidence profile consists of two
components: an assessment of the quality of evidence
and a summary of the findings [37]. This work will build
on a pilot database developed by the GRADE Working
Group (www.gradeprofiles.org/). We will establish an
advisory group with representatives from producers of
guidelines and systematic reviews to obtain input into
key decisions, including quality control, inclusion of
metadata, and access to the database. In addition to
organisations that are partners in DECIDE, we will in-
vite representatives from the Cochrane Collaboration,
the G-I-N, and the International Network of Agencies
for Health Technology Assessment (INAHTA) to join
the advisory group. The role of the advisory group will
be to help ensure that the database is optimally
designed to minimize unnecessary duplication of efforts
and maximize access to evidence profiles by guideline
developers and HTA agencies in Europe.
The profile database will accommodate the changing
and evolving nature of the grading methodology over
time (such as empirical evidence from DECIDE). This
makes storing static documents (such as pdf files of fin-
ished evidence profiles) less appealing. Instead, the data-
base will store the individual data points, e.g., effect
sizes, and the evidence profile will be re-created on de-
mand. This allows for flexibility in providing different
profile presentations that can be utilized for targeted
user testing in randomized trials and allows creating dif-
ferent output formats, such as pdf files, rich text for-
mats, or in graphical form. In addition, the original data
set can be downloaded at any time for reuse and for easy
updating at a later time point or by other authors. GRADE
profiles will be conceptually stored in three separate com-
ponents: the profile identifiers (e.g., profile name), patient
or population-important outcomes (including quality of
evidence rating and estimate of effect), as well as annota-
tions (footnotes, which provides the rational for the evi-
dence rating and additional explanations).
Other tools and resources may also be developed. For
example, documents providing guidance to guideline
developers about how best to present information to the
public or policymakers.
Preliminary results
Table 2 provides an overview of the strategies currently
being developed and user tested for work packages 1 to 5.
The preliminary results are available at the DECIDE web-
page (http://www.decide-collaboration.eu/work-packages-
strategies). WP1’ user-testing of presentation formats has
so far resulted in an electronic multilayered guideline
Table 2 Strategies being developed by DECIDE
WP1 clinicians WP3 consumers WP4 diagnostic tests WP2
coverage
decisions
WP5 health
system
decisions
Presentation of
evidence and
recommendations
Top Layer presentation
Explanations of key concepts
Interactive Summary of Findings tables/ videos
Frameworks for
going from evidence
to recommendations
Evidence to recommendation frameworks * See note Evidence to
recommendation
framework
Costing frameworks
Decision support Decision aids Decision aids and Evidence to
decision frameworks
Evidence to decision
frameworks
Communication
strategies
Point of care applications
Multilayered guidelines in
electronically structured
outputs
Point of care applications
and Guidance and tools
for guideline producers
Adaptation of point of care
applications and Guidance and
tools for guideline producers
* Recommendations for coverage decisions are not common. Typically these decisions are made by responsible groups in each jurisdiction or organisation,
although sometimes technical support staff will recommend a decision that is then considered by those responsible for making the decision.
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forms (e.g., for websites, smartphone apps, and electronic
health records). Figure 3 gives an example of this multi-
layered presentation format with what we call the guide-
line top layer, which presents the minimum amount of
information that a health professional would need to
understand and act on a recommendation. The top layer
presentation is being implemented in an adaptation of a
national antithrombotic guideline in Norway [38]. This
guideline will be presented in an electronic multilayered
guideline on the web and in smartphone applications.
WP1 has through this research identified the need to
develop the presentation formats in parallel with devel-
opment of the Guideline Development Tool to facilitate
the authoring of guideline content and creation of the
various electronic outputs. This will require specific
functionality in the Guideline Development Tool to be
developed in WP6. Work packages 1, 3, 4, and 5 are
developing frameworks for going from evidence to recom-
mendations as a means of supporting recommendations
that are well informed by evidence. These frameworks
build on the previous work of the Decision Table. WP2
(policymakers) will focus specifically on coverage deci-
sions, for which recommendations are uncommon. WP1
is also developing an Evidence To Recommendation Table
for healthcare professionals. This table aims to be a friend-
lier Summary of Findings Table that includes other fea-
tures as values and preferences and resource use.
The Evidence to Recommendation Frameworks (see
Additional files 1, 2 and 3 for examples) aim to provide
the basis for communicating to users the justification for
a recommendation and the basis for decision support
tools, which are being developed for all five work
packages. For individual patient decisions, these tools
will be decision aids or recommendation presentationsthat can be derived directly from Summary of Findings
Tables and the Evidence To Recommendation Frame-
works. Those responsible for policy decisions will be
assisted by Evidence to Decision Frameworks, decision
support tools that will assist decision makers to trans-
parently make judgements, and eventually decisions,
informed by available evidence. Clear definitions of the
criteria used in the frameworks will be provided in order
to increase transparency of the process.
Work packages 2 and 5 are in addition developing and
testing frameworks for considering costs in relation to
coverage decisions and health system decisions respectively.
We are additionally developing and testing explana-
tions of key concepts and interactive Summary of Find-
ings Tables that will be adapted for use across all five
work packages and their final strategies (e.g., Evidence to
Recommendations Frameworks). The explanations will
include brief explanations of concepts such as ‘quality of
evidence’ or ‘confidence intervals’ that can, for example,
be used as cursor-over help in guidelines, or Summary
of Findings Tables. In addition, we will develop longer
explanations using videos, interactive applications, or
other presentations to facilitate understanding. These
can be provided as help using hypertext links in, for ex-
ample, online guidelines, as resources or a help file on
guideline producers’ websites or in resources, such as
the Cochrane Library, as an open access online resource,
or as an introduction to a group making recommenda-
tions or decisions. The objective of this interactive work
is to improve understanding and use of evidence of the
effects of healthcare interventions by developing pro-
ducts (e.g., interactive Summary of Findings Tables) that
allows producers to tailor a presentation to different
target audiences and for users to interact with the
presentation.
Figure 3 Prototype of a DECIDE communication strategy for health professionals.
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velopment.org) will build on the features of GRADEpro
and include:
1. Learning modules about a guideline development.
2. Export of evidence syntheses to a database of
evidence profiles.
3. Support for communication, polling, managing
conflict of interest, voting, and other forms of
interaction among multiple stakeholders providing
input (e.g., guideline panel members).
4. Ergonomic text editor with essential functions
including text formatting, tables, inserting images,
providing footnotes and explanations, tracking
changes, and inserting references from an integrated
reference manager.
5. Ability to create templates to produce various types
of electronic and printable documents based on the
information collected at each step of the process.
6. Interactive Summary of Findings Tables.The full list of functionality, as well as the current list
of learning modules being developed for the Guideline
Development Tool is available in Additional file 4.
Additional communication strategies for clinicians will
include point of care applications to support the provision
of clinical recommendations linked to medical records, as
parts of clinical decision support systems, and on smart-
phones or tablets. For patients, these will include access to
decision aids at the point of care, to be used in consulta-
tions with their clinicians, and tools to assist guideline
developers in developing versions of guidelines that are
easily accessible to targeted patients.Discussion
DECIDE will directly address how information about
healthcare interventions are created, packaged, transmitted,
and interpreted among a variety of important stakeholder
groups including healthcare professionals, healthcare man-
agers, policymakers, and patients.
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http://www.implementationscience.com/content/8/1/6DECIDE will build on the substantial experience and
knowledge of the GRADE Working Group. The GRADE
Working Group has so far focused on a system for struc-
turing judgements about the quality of evidence and
strength of recommendations and there is an emerging
consensus around this approach [16,18,20]. In addition,
the Working Group has developed and evaluated ways of
presenting concise summaries of the findings of systematic
reviews (as the basis for recommendations or decisions) to
health professionals, and has contributed to ways of pre-
senting this information to guideline developers, policy-
makers, and patients [21-25,28]. The Group has also
addressed considerations for applying the GRADE system
to recommendations about diagnostic tests and health sys-
tem policies [23,24,28]. This work has been essential but
does not address issues around how best to package and
deliver GRADE recommendations to health professionals,
policymakers, patients, and others. In fact, little research
has been done in this field [12,39,40].
Based on this work DECIDE will develop and evaluate
ways of effectively communicating and supporting the up-
take of evidence-based recommendations (and the basis
for such recommendations). This work will advance the
state-of-the-art by taking the successful GRADE system
and providing new research data on the most effective
ways of using GRADE to develop and disseminate research
evidence to key clinical practice stakeholders across differ-
ent countries, health systems, and settings in Europe. It will
provide new information on how to tailor global research
evidence to local needs. Moreover, DECIDE is also a part-
ner in a research programme called MAGIC (Making
GRADE the Irresistible Choice, http://www.magicproject.
org/), which develops methodology and technology to inte-
grate guidelines in the electronic medical record (as clinical
decision support systems) and to facilitate local adaptation
and dynamic updating of healthcare recommendations.
It is likely that the way in which recommendations are
formulated needs to be adapted to the specific character-
istics of a guideline. Providing empirically-based infor-
mation on how this might be done is what DECIDE
aims to achieve. DECIDE will advance the state-of-the
art by first collecting data on stakeholders’ opinions of
alternative ways of presenting recommendations and
then obtain empirical evidence of the utility of these
strategies by running a series of randomized controlled
trials in a range of European countries. The data from
these trials will be used to inform the optimal presenta-
tion of recommendations in real clinical guidelines pro-
duced by the guideline developers in our consortium, as
well as others through the GRADE Working Group.
DECIDE’s rigorous assessment of the effectiveness of
communication strategies will provide an empirical basis
for better understanding of the factors that influence the
effectiveness of communication strategies on the variousactors in the healthcare sector. The impact of these
strategies on knowledge, attitudes, and self-reported be-
haviour will then be evaluated. The impact will therefore
be felt not only at a clinical level, but across diverse
healthcare settings within European healthcare systems
and elsewhere.
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